Beckman Coulter Diagnostics
BEC
Performance
About Beckman Coulter Diagnostics
Beckman Coulter Diagnostics provides clinical diagnostics solutions that help healthcare professionals obtain accurate, timely diagnostic information across laboratories and patient care settings. The company focuses on core disciplines such as chemistry, hematology, immunoassay, microbiology, urinalysis, and blood banking, with additional emphasis on automation, advanced informatics, and clinical decision support to streamline workflows from the lab to the clinic. Their offerings address global laboratories and health systems, delivering actionable insights to improve patient outcomes. The organization operates within the diagnostics industry, with a presence in South Africa and other regions as indicated by country/region selections on their site.
Recent News
Maternal Serum Ferritin Across Gestation and Risk of Small-for-Gestational-Age: A Longitudinal Cohort Study
Prevalence of Borderline Elevated and Elevated Cholesterol Among New Adult Patients From 23 Hospitals in 12 Cities of Jiangsu Province: A Multicenter Cross-Sectional Study
Associations Between Dietary Inflammatory Potential and COPD: The Mediating Role of Inflammation
Beckman Coulter Diagnostics Earns CE Mark for New Assay Delivering Bacterial vs Viral Infection Results in Approximately 20 Minutes
Automata Secures $45M Series C to Build the Operating System for AI-Ready Labs
FAR Part 13: Can I Wait to Protest When the Agency Tells Me a Debriefing Will Be Provided?
Ultra-Rapid Nanoplasmonic Colorimetry in Microfluidics for Antimicrobial Susceptibility Testing Directly From Specimens
Recent Deals
No recent deals for this company.